Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Antiphospholipid Antibodies: Paradigm in Transition Publisher Pubmed



Horstman LL1 ; Jy W1 ; Bidot CJ1 ; Ahn YS1 ; Kelley RE2 ; Zivadinov R3 ; Maghzi AH4 ; Etemadifar M4 ; Mousavi SA4 ; Minagar A2
Authors

Source: Journal of Neuroinflammation Published:2009


Abstract

Objectives: This is a critical review of anti-phospholipid antibodies (aPL). Most prior reviews focus on the aPL syndrome (APS), a thrombotic condition often marked by neurological disturbance. We bring to attention recent evidence that aPL may be equally relevant to non-thrombotic autoimmune conditions, notably, multiple sclerosis and ITP. Organization: After a brief history, the recent proliferation of aPL target antigens is reviewed. The implication is that many more exist. Theories of aPL in thrombosis are then reviewed, concluding that all have merit but that aPL may have more diverse pathological consequences than now recognized. Next, conflicting results are explained by methodological differences. The lupus anticoagulant (LA) is then discussed. LA is the best predictor of thrombosis, but why this is true is not settled. Finally, aPL in non-thrombotic disorders is reviewed. Conclusion: The current paradigm of aPL holds that they are important in thrombosis, but they may have much wider clinical significance, possibly of special interest in neurology. © 2009 Horstman et al; licensee BioMed Central Ltd.
Other Related Docs
15. Vascular Lesions in Lupus Nephropathy, Journal of Isfahan Medical School (2014)